Kidney Disease Research
Maze Therapeutics Inc. is focused on clinical research in APOL1 kidney disease, with attention to adult patients affected by proteinuria and related renal impairment.
- APOL1-associated nephropathy
- Proteinuric kidney disease
- Renal function
The sponsor’s research activity is centered on therapeutic approaches for inherited and molecularly defined forms of kidney disease.
Nephrology and Renal Medicine
Clinical interest extends to the broader nephrology field, particularly conditions involving persistent proteinuria and progressive renal damage.
- Renal pathology
- Proteinuria
- Chronic kidney impairment
Research activity in this area reflects a therapeutic focus on medically significant forms of renal disease with unmet clinical need.
Genetic and Molecular Kidney Disorders
The sponsor is involved in research on genetically driven kidney disorders, with emphasis on the APOL1 pathway and its role in renal injury.
- APOL1 biology
- Genetic risk factors
- Molecular renal disease
This area highlights interest in targeted treatment strategies for monogenic and genotype-linked renal disease.
Adult Therapeutics
Maze Therapeutics Inc. is conducting research in adult medicine for patients with established kidney disease, with clinical attention to safety and tolerability in this population.
- Adult patient care
- Renal safety
- Tolerability assessment
Its clinical focus includes therapeutic development for adults living with proteinuric renal disease.
